Back

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 3 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

7 More presentations in this session

Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Abstract Slides
Presentation thumbnail
Professor T. Weiss (St. Polten, AT)
Abstract
Presentation thumbnail
Professor E. Klok (Leiden, NL)
Abstract
Presentation thumbnail
Doctor E. Choi (Seoul, KR)
Abstract
Presentation thumbnail
Professor Y. Guo (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 3

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Real-world insights on anticoagulation therapies in non-valvular atrial fibrillation: a comprehensive electronic health record-based study using natural language processing and machine learning
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
thumbnail
Congress Presentation
Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources